| Literature DB >> 32754705 |
Kimberly K Somers1, Ruchi Amin1, Kathleen M Leack1, Melissa Lingongo1, Marjorie J Arca1, David M Gourlay1.
Abstract
BACKGROUND: Perioperative care after appendectomy may be the first exposure to opioids for many children. A quality improvement project was implemented to assess current practice of prescribing pain medications after a laparoscopic appendectomy to decrease unnecessary opioid use via simple, targeted steps.Entities:
Year: 2019 PMID: 32754705 PMCID: PMC7391896 DOI: 10.1016/j.sopen.2019.08.001
Source DB: PubMed Journal: Surg Open Sci ISSN: 2589-8450
Fig 1Tools utilized by the QI team to plan and implement QI project.
A, Driver diagram depicting the primary and secondary drivers with possible interventions.
B, Fishbone diagram used to define the potential causes of an appendectomy postoperative pain management process to identify root causes for interventions with PDSAs.
Fig 2Flowchart showing timeline of development and implementation of opioid reduction quality improvement protocol for acute appendicitis patients.
Comparison of preimplementation groups with demographics and outcome variables
| Preimplementation | Postimplementation | ||
|---|---|---|---|
| No. of patients with laparoscopic appendectomy for acute appendicitis | 814 | 263 | NA |
| Male (%) | 478 (58.7%) | 154 (58.6%) | .962 |
| Median age in years (range) | 12.3 (1.0–20.3) | 12.2 (3.7–18.4) | .420 |
| Median total IV postop opioid doses (range) | 0 (0–7) | 0 (0–0) | <.001 |
| Median total enteral postop doses (range) | 2 (0–14) | 0 (0–4) | < .001 |
| Patients with opioid prescription at discharge (%) | 793 (97.4) | 176 (66.9) | < .001 |
| Median no. of opioid doses prescribed (range) | 17 (2–139) | 5 (2–20) | < .001 |
| Opioid prescriptions filled (ePDMP review) (%) | 474 (59.8) | 110 (62.5) | .5514 |
| No. of patients with return for pain | Readmission: 3 | Readmission: 1 | .7407 |
| No. of patients with return for constipation | Readmission: 5 | Readmission: 3 | .6485 |
| Median length of stay in hours (range) | 21.9 (2.0–95.6) | 17.2 (1.1–68.5) | < .001 |
Comparison of preimplementation and postimplementation groups with demographics. Statistical significance was demonstrated for parenteral and enteral opioid use postoperatively, prescriptions provided and filled at discharge, total doses of opioids prescribed, and length of stay. T, t-test; C, χ2; W, Wilcoxon rank sum test; +, exact test.
ePDMP, Enhanced Prescription Drug Monitoring Program.
χ2 test.
Fisher exact test.
Wilcoxon rank sum test.
Fig 3Controls charts specifying upper and lower control limits for assessing variability in conforming to the QI process. The center line is the expected value of proportions based on the sample size. The arrow denotes the point when the protocol was fully implemented (September 2017 to December 2018). The sample size for the control chart is consistent with the upper and lower limits of the distribution with a similar sample size. Controls charts A-D demonstrate consistent practice for the QI process with no special cause variation determined. A, Utilization for the postimplementation period of parenteral opioids. B, Utilization of enteral opioids. C, Discharge opioids for the postimplementation. D, Returns to health care system P chart for assessment of outcomes.